• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.

作者信息

Riter Henry G, Redfield Margaret M, Burnett John C, Chen Horng H

出版信息

J Am Coll Cardiol. 2006 Jun 6;47(11):2334-5. doi: 10.1016/j.jacc.2006.03.013. Epub 2006 May 16.

DOI:10.1016/j.jacc.2006.03.013
PMID:16750705
Abstract
摘要

相似文献

1
Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.在急性失代偿性心力衰竭和肾功能不全患者中，与标准剂量奈西立肽相比，非低血压低剂量奈西立肽具有不同的肾脏效应。
J Am Coll Cardiol. 2006 Jun 6;47(11):2334-5. doi: 10.1016/j.jacc.2006.03.013. Epub 2006 May 16.
2
Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.奈西立肽不能改善慢性心力衰竭且血清肌酐恶化患者的肾功能。
Circulation. 2004 Sep 21;110(12):1620-5. doi: 10.1161/01.CIR.0000141829.04031.25. Epub 2004 Aug 30.
3
Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.急性失代偿性心力衰竭治疗中的争议与冲突：奈西立肽作为循证治疗方法
Pharmacotherapy. 2007 May;27(5):619-25. doi: 10.1592/phco.27.5.619.
4
Nesiritide: harmful or harmless?奈西立肽：有害还是无害？
Pharmacotherapy. 2006 Oct;26(10):1465-78. doi: 10.1592/phco.26.10.1465.
5
Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.评估急性失代偿性心力衰竭中的呼吸困难：ASCEND-HF（急性心力衰竭中奈西立肽临床疗效的研究）对呼气峰流速的贡献的见解。
J Am Coll Cardiol. 2012 Apr 17;59(16):1441-8. doi: 10.1016/j.jacc.2011.11.061.
6
Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.奈西立肽（人B型利钠肽）与多巴酚丁胺对失代偿性心力衰竭患者心率变异性的影响
Am Heart J. 2004 Nov;148(5):e16. doi: 10.1016/j.ahj.2004.05.027.
7
Nesiritide speeds recovery time for heart failure patients.奈西立肽可缩短心力衰竭患者的康复时间。
Manag Care. 2004 Jul;13(7):60-1.
8
Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).奈西立肽门诊输注在晚期心力衰竭合并肾功能不全患者中的潜在应用（来自奈西立肽随访系列输注[FUSION I]试验）
Am J Cardiol. 2006 Jul 15;98(2):226-9. doi: 10.1016/j.amjcard.2006.01.081. Epub 2006 May 19.
9
Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics.
Pharmacotherapy. 2006 Feb;26(2):277-80. doi: 10.1592/phco.26.2.277.
10
Optimizing treatment of chronic decompensated heart failure in the outpatient setting.
Rev Cardiovasc Med. 2004;5 Suppl 4:S28-36.

引用本文的文献

1
Renal Effects of Combination Phosphodiesterase V Inhibition and Low-Dose B-Type Natriuretic Peptide in Acute Heart Failure: A Randomized Clinical Trial.磷酸二酯酶5抑制与低剂量B型利钠肽联合应用对急性心力衰竭的肾脏影响：一项随机临床试验
Circ Heart Fail. 2024 Dec;17(12):e011761. doi: 10.1161/CIRCHEARTFAILURE.124.011761. Epub 2024 Nov 8.
2
Incidence, mortality, and predictors of acute kidney injury in patients with heart failure: a systematic review.心力衰竭患者急性肾损伤的发生率、死亡率和预测因素：系统评价。
ESC Heart Fail. 2023 Dec;10(6):3237-3249. doi: 10.1002/ehf2.14520. Epub 2023 Sep 13.
3
Osteocrin, a bone-derived humoral factor, exerts a renoprotective role in ischemia-reperfusion injury in mice.
骨钙素，一种骨源性体液因子，在小鼠缺血再灌注损伤中发挥肾保护作用。
Nephrol Dial Transplant. 2022 Feb 25;37(3):444-453. doi: 10.1093/ndt/gfab286.
4
Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan.治疗心肾综合征的药理学方法：血管扩张性强心剂左西孟旦的作用
Eur Heart J Suppl. 2017 Mar;19(Suppl C):C22-C28. doi: 10.1093/eurheartj/sux002. Epub 2017 Mar 8.
5
Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide.血清白蛋白水平降低对急性失代偿性心力衰竭患者急性肾损伤的影响：心房利钠肽的潜在关联
Heart Vessels. 2017 Aug;32(8):932-943. doi: 10.1007/s00380-017-0954-y. Epub 2017 Feb 7.
6
Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal Syndrome.血流动力学性心肾综合征的当前及潜在治疗策略
Cardiorenal Med. 2016 Feb;6(2):83-98. doi: 10.1159/000441283. Epub 2015 Nov 6.
7
The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials.奈西立肽对急性失代偿性心力衰竭患者肾功能的剂量依赖性效应：一项随机对照试验的系统评价和荟萃分析
PLoS One. 2015 Jun 24;10(6):e0131326. doi: 10.1371/journal.pone.0131326. eCollection 2015.
8
Therapeutic adjustments in stage D heart failure: challenges and strategies.D期心力衰竭的治疗调整：挑战与策略
Curr Heart Fail Rep. 2015 Feb;12(1):15-23. doi: 10.1007/s11897-014-0240-6.
9
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.低剂量多巴胺或低剂量奈西立肽治疗肾功能障碍的急性心力衰竭：ROSE 急性心力衰竭随机试验。
JAMA. 2013 Dec 18;310(23):2533-43. doi: 10.1001/jama.2013.282190.
10
Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.急性心力衰竭时针对肾脏：老药能否带来新益处？急性心力衰竭肾脏优化策略评估（ROSE AHF）试验。
Circ Heart Fail. 2013 Sep 1;6(5):1087-94. doi: 10.1161/CIRCHEARTFAILURE.113.000347.